Hong Kong Baptist University develops new aptamer drug for bone anabolic therapies

HONG KONG SAR - Media OutReach - 19 December 2022 - A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone anabolic therapies using a selected aptamer that serves as an inhibitor of sclerostin, a protein that prevents bone growth.
Read more: Hong Kong Baptist University develops new aptamer drug for bone anabolic therapies